Jean-Claude Lubanda

Relationship between X-inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population

Robert Dobrovolný, Lenka Dvořáková, J. Ledvinová et al. · Journal of Molecular Medicine · 2005 · 168 citations

Biology, Mendelian Disorder, Genetic Disorder +7

Natural history of the respiratory involvement in Anderson–Fabry disease

Sudheera Magage, Jean-Claude Lubanda, Z Susa et al. · Journal of Inherited Metabolic Disease · 2007 · 63 citations

Evaluation of a low dose, after a standard therapeutic dose, of agalsidase beta during enzyme replacement therapy in patients with Fabry disease

Jean-Claude Lubanda, Ene Anijalg, Vladimı́r Bzdúch et al. · Genetics in Medicine · 2009 · 61 citations · Full text

Standard Therapeutic Dose, Low Dose, Enzyme Replacement Therapy +3

Percutaneous Mechanical Thrombectomy Using Rotarex® S Device in Acute Limb Ischemia in Infrainguinal Occlusions

Samuel Heller, Jean-Claude Lubanda, P Vařejka et al. · BioMed Research International · 2017 · 51 citations · Full text

Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative

Derralynn Hughes, Patrício Aguiar, Patrick Deegan et al. · BMJ Open · 2020 · 37 citations · Full text